Cosmos Holdings Aktie

Cosmos Health reports receipt of initial orders for C-ScrubVet Wash 4% CHDG, an antimicrobial veterinary product for dogs, cats and horses. The 500-ml bottles are certified to EN 1656 and EN 1657; distribution began in the United Kingdom and is planned to expand to other European markets from Q4 2026. Production takes place at Cana Laboratories in Athens; distribution follows a multichannel strategy via e-commerce, pet specialty retailers and veterinary clinics. Cosmos Health links the new line to its existing C-Scrub brand and positions itself in the growing global animal health market. » Altro su de.investing.com

Cosmos Health has fully repaid a senior secured $8.0 million convertible note with a 9% coupon that was issued in August 2025, twelve months before its August 2027 maturity. The early repayment prevents potential conversions and equity dilution; the company has also withdrawn its S-1 and S-3 registration statements and currently has no shelf registration or at‑the‑market program. Operating cash burn in H1 2026 was more than 30% below the two‑year average, total liabilities fell by $6.27 million in Q2, and shareholders’ equity rose by 12.2%. Cosmos Health holds digital assets (Bitcoin at a gain), intellectual property and real estate, and continues a $5 million share repurchase program. » Altro su de.investing.com